Invesco Pharmaceuticals ETF
PJP
86 hedge funds and large institutions have $75.5M invested in Invesco Pharmaceuticals ETF in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 40 reducing their positions, and 13 closing their positions.
0.99% less ownership
Funds ownership: 26.36% → 25.37% (-0.99%)
8% less funds holding
Funds holding: 93 → 86 (-7)
25% less capital invested
Capital invested by funds: $101M → $75.5M (-$25.1M)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
68% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 40
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.29M |
| 2 |
QAM
Q3 Asset Management
Birmingham,
Michigan
|
+$588K |
| 3 |
5L
55I LLC
Boston,
Massachusetts
|
+$394K |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$144K |
| 5 |
Morgan Stanley
New York
|
+$118K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$3.38M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.67M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.6M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.13M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$687K |
PJP Hedge Fund Activity: Q1 2020 in Review
86 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2020, worth a combined $75.5M — down 25% from $101M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of PJP and 9 opened new positions — a net loss of 4 holders — while 40 trimmed existing stakes and 13 added.
The largest buyer was Ameriprise, adding an estimated $1.29M. The largest seller was Bank of America, cutting an estimated $3.38M.
- 86 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2020, down from 93 in Q4 2019.
- Funds reported $75.5M of Invesco Pharmaceuticals ETF stock for Q1 2020, down 25% quarter-over-quarter.
- 9 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2020 and 13 closed out, a net change of -4 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q1 2020 was Ameriprise, an estimated $1.29M added.
- The largest Invesco Pharmaceuticals ETF seller in Q1 2020 was Bank of America, an estimated $3.38M sold.
Based on aggregated 13F filings for Q1 2020.